31 January 2020
We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Robert Glynne-Jones at Spire include:
Major research interest is in the treatment of rectal and anal cancer, and chemoradiation. Current areas of research include investigation of resistance mechanisms/predictive factors for response to chemoradiation in anal and rectal cancer, DCE-MRI changes, examination of tumour interstitial pressure and the development of novel chemoradiation regimens. I am also interested in defining an optimal field size for radiation for different stages.
I am intrigued by the evidence that the biologicals have not yet delivered on their original promise in combination with radiation. I am Principle Investigator of studies in rectal and anal cancer integrating novel drugs into Chemoradiation regimens.
|Telephone||020 8901 5555|
|Private secretary||Pippa Lofthouse-Smith|
|Private secretary email@example.com|
21 October 2019
Read our latest Q and A with ENT Consultant, Mr Jonathn Hughes on head and neck cancer.